Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapiesLars Masanneck, Marc Pawlitzki, Alice Willison et al.|Multiple Sclerosis and Related Disorders|2022Cited by 21
Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohortPaula Quint, Tobias Ruck, Uwe Maus et al.|Journal of Neurology|2024Cited by 18
Driving time-based identification of gaps in specialised care coverage: An example of neuroinflammatory diseases in GermanyLars Masanneck, Marc Pawlitzki, Christina B. Schroeter et al.|Digital Health|2023Cited by 16
Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignanciesSaskia Räuber, Nico Melzer, Kristin S. Golombeck et al.|Journal of Neuroinflammation|2024Cited by 10